Timothy Mullett, MD, leaned toward his computer screen as he spoke, drowning out the sounds of the busy coffee shop behind him to get his message across.

During a Case-Based Roundtable® event, Ticiana Leal, MD, discusses phase 3 trials of combinations in the non–small cell lung ...

Cancer is the second leading cause of death in the U.S., but research shows that at least 42% of new cancer cases are ...

Three tobacco giants would pay close to $25 billion to provinces and territories and more than $4 billion to tens of thousands of Quebec smokers and their loved ones as part of a newly proposed deal ...

A significant weapon in the fight against lung cancer may be going to waste, as a survey revealed most Americans aren’t aware ...

In the randomized, double-blind, phase 3 study, experts explored treatment with neoadjuvant pembrolizumab (Keytruda) plus chemotherapy, followed by adjuvant pembrolizumab, in patients aged 18 years ...

Novocure received a long-sought FDA approval for the use of its Tumor Treating Fields technology against metastatic non-small ...

Cervical cancer remains the most widespread cause of cancer death in women in the country, accounting for 12 percent of all cancer deaths recorded in Zimbabwe. Prostate cancer is the second most ...

MACON, Georgia (41NBC/WMGT) – Atrium Health Navicent has been using a new minimally-invasive procedure to diagnose lung cancer. Atrium Health Navicent cardiothoracic surgeon, Dr. Anthony Holden, says ...

Research published in Nature Genetics on Oct.14, by Yale Cancer Center researchers at Yale School of Medicine, found a higher ...

Patients, pathologists, clinicians, researchers, radiologists and others from around the world recently gathered for the 2024 ...

Good Samaritan will be having Lung Cancer Screening Days at the beginning of November. Those who are eligible include people ...